Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03OSG
|
||||
Former ID |
DCL000162
|
||||
Drug Name |
MBX-8025
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Dyslipidaemias; Hyperlipidaemia; Obesity [ICD9: 272, 272.0-272.4, 278; ICD10:E78, E66] | Phase 2/3 | [548328] | ||
Company |
Metabolex
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H18F3N3O3S
|
||||
Canonical SMILES |
CC1=C(C=CC(=C1)SCC2=NN(N=C2C)C3=CC=C(C=C3)C(F)(F)F)OCC(<br />=O)O
|
||||
InChI |
1S/C20H18F3N3O3S/c1-12-9-16(7-8-18(12)29-10-19(27)28)30-11-17-13(2)24-26(25-17)15-5-3-14(4-6-15)20(21,22)23/h3-9H,10-11H2,1-2H3,(H,27,28)
|
||||
InChIKey |
XJHXZGHPCAKRFK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Peroxisomeproliferator activated receptor delta | Target Info | Agonist | [525344] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | Wnt signaling pathway | ||||
Pathway Interaction Database | Presenilin action in Notch and Wnt signaling | ||||
RXR and RAR heterodimerization with other nuclear receptor | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.